Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Mar;26(3):631-43.
doi: 10.1007/s11095-008-9801-2. Epub 2008 Dec 18.

PEG hydrogels for the controlled release of biomolecules in regenerative medicine

Chien-Chi Lin  1 , Kristi S Anseth
Affiliations
Review

PEG hydrogels for the controlled release of biomolecules in regenerative medicine

Chien-Chi Lin et al. Pharm Res. 2009 Mar.

Abstract

Polyethylene glycol (PEG) hydrogels are widely used in a variety of biomedical applications, including matrices for controlled release of biomolecules and scaffolds for regenerative medicine. The design, fabrication, and characterization of PEG hydrogels rely on the understanding of fundamental gelation kinetics as well as the purpose of the application. This review article will focus on different polymerization mechanisms of PEG-based hydrogels and the importance of these biocompatible hydrogels in regenerative medicine applications. Furthermore, the design criteria that are important in maintaining the availability and stability of the biomolecules as well as the mechanisms for loading of biomolecules within PEG hydrogels will also be discussed. Finally, we overview and provide a perspective on some of the emerging novel design and applications of PEG hydrogel systems, including the spatiotemporal-controlled delivery of biomolecules, hybrid hydrogels, and PEG hydrogels designed for controlled stem cell differentiation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) Simplified crosslinked hydrogel structure. Black dots represent crosslinking point; ξ represents mesh size of the gel. (B) Hydrogel property as a function of gel crosslinking density.
Figure 2
Figure 2
Schematic structures of PEG hydrogels formed via: (A) chain-growth, (B) step-growth, and (C) mixed-mode step and chain growth polymerization. (Components not scale to actual size)
Figure 3
Figure 3
Chemical structures of PEG macromer and its di(meth)acrylate derivatives that often solution polymerize to form hydrogel networks useful for cell encapsulation and other biomaterial applications.
Figure 4
Figure 4
Schematic of methods for loading of therapeutics into PEG hydrogels: (A) Entrapment: Drugs are loaded into hydrogels via in situ entrapment or post-fabrication equilibrium partitioning. (B) Tethering: Drugs are modified with a crosslinkable and cleavable linker that can be liberated once the tethers are degraded hydrolytically or enzymatically. (C) Multiphase loading: Drugs are pre-loaded into microparticles that are subsequently entrapped in hydrogels. (Components not scale to actual size)
See this image and copyright information in PMC

References

    1. Lutolf MP, Hubbell JA. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnology. 2005;23:47–55. - PubMed
    1. Lin CC, Metters AT. Hydrogels in controlled release formulations: Network design and mathematical modeling. Advanced Drug Delivery Reviews. 2006;58:1379–1408. - PubMed
    1. Peppas NA, Bures P, Leobandung W, Ichikawa H. Hydrogels in pharmaceutical formulations. European Journal of Pharmaceutics and Biopharmaceutics. 2000;50:27–46. - PubMed
    1. Peppas NA, Hilt JZ, Khademhosseini A, Langer R. Hydrogels in biology and medicine: From molecular principles to bionanotechnology. Advanced Materials. 2006;18:1345–1360.
    1. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003;24:4337–4351. - PubMed

Publication types